Activist & passive stakes

Investors crossing the 5% ownership line, from SEC Schedule 13D (activist) and 13G (passive) filings. Newest first.

Showing the last 10 days.Sign up free for 90 days
Amendments only.1–9 of 9
  • PassiveAmendment 9
    Nov 12, 2026
    THO · Thor Inds Inc
    Kayne Anderson Rudnick Investment Management, LLC
    5.2% · 2,690,130 shSEC
  • PassiveAmendment 3
    Nov 12, 2026
    PTHS · Pelthos Therapeutics Inc.
    3i, LP
    9.9% · 383,447 shSEC
  • PassiveAmendment 1Below 5%
    Nov 12, 2026
    AUTL · Autolus Therapeutics PLC
    Qatar Investment Authority
    3.5% · 9,184,404 shSEC
  • PassiveAmendment 5Below 5%
    Nov 10, 2026
    PHAT · Phathom Pharmaceuticals Inc
    Invesco Ltd.
    0% · 30,562 shSEC
  • PassiveAmendment 4
    Nov 10, 2026
    BCDA · BioCardia, Inc.
    Thomas A. Satterfield, Jr.
    9.9% · 1,539,134 shSEC
  • PassiveAmendment 4
    Nov 10, 2026
    CRIS · Curis, Inc.
    Thomas A. Satterfield, Jr.
    8.8% · 616,565 shSEC
  • PassiveAmendment 1Below 5%
    Nov 10, 2026
    NVNO · enVVeno Medical Corporation
    Thomas A. Satterfield, Jr.
    4.8% · 33,470 shSEC
  • PassiveAmendment 3
    Nov 10, 2026
    OSTX · OS Therapies Incorporated
    Thomas A. Satterfield, Jr.
    9.9% · 5,434,150 shSEC
  • PassiveAmendment 2Below 5%
    Nov 6, 2026
    LIFE · Ethos Technologies Inc.
    Gv 2021, L.P.
    1.8% · 571,907 shSEC